Isda AGM: US regulator identifies six weaknesses in OTC market

While praising the derivatives industry for the strides it has made in improving operations infrastructure - specifically, the reduction in backlogs and improvements in novations processing - Lubke said there is still an over-reliance on manual processes. "There are still a lot of improvements needed to automate the market in a strong and efficient manner," he remarked.

The second area of concern for regulators, Lubke added, was what he referred to as "structural design weaknesses in how

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...


You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: